Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen, II: Tolerance induction on memory B cells

Blood

Volumn 102, Issue 1, 2003, Pages 229-236

  Mohiuddin, Muhammad M ^b   Ogawa, Haruko ^b   Yin, Deng Ping ^b   Galili, Uri ^a  

^a RUSH UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; CARBOHYDRATE ANTIGEN; EPITOPE; GALACTOSE; GALACTOSYLTRANSFERASE; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BLOOD GROUP; CONTROLLED STUDY; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; IRRADIATION; KNOCKOUT MOUSE; LYMPHOCYTE; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SWINE; T LYMPHOCYTE ACTIVATION; TRANSPLANTATION; XENOGRAFT;

EID: 0038305482     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-11-3515     Document Type: Article

References (37)

1. Thall AD, Maly P, Lowe JB. Oocyte Galα1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J Biol Chem. 1995;270:21437-21440.
2. Galili U, Clark MR, Shohet SB, Buehler J, Macher BA. Evolutionary relationship between the natural anti-Gal antibody and the Galα1-3Gal epitope in primates. Proc Natl Acad Sci U S A. 1987;84:1369-1373.
3. Galili U, Shohet SB, Kobrin E, Stults CL, Macher BA. Man, apes, and Old World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J Biol Chem. 1988;263:17755-17762.
4. Kabat EA. Blood Group Substances: Their Chemistry and Immunochemistry. New York, NY: Academic Press; 1956.
5. Watkins WM. Blood-group substances, Science. 1966;152:172-181.
6. Galili U, Rachmilewitz EA, Peleg A, Flechner I. A unique natural human IgG antibody with anti-α-galactosyl specificity. J Exp Med. 1984;160:1519-1531.
7. Galili U, Macher BA, Buehler J, Shohet SB, Human natural anti-α-galactosyl IgG, II: the specific recognition of α(1-3)-linked galactose residues. J Exp Med. 1985;162:573-582.
8. Galili U, Buehler J, Shohet SB, Macher BA. The human natural anti-Gal IgG, III: the subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies. J Exp Med. 1987;165:693-704.
9. Galili U, Mandrell RE, Hamadeh RM, Shohet SB, Griffiss JM. Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun. 1988:56:1730-1737.
10. Galili U. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today, 1993;14:480-482.
11. Good H, Cooper DKC, Malcolm AJK, et al. Identification of carbohydrate structures which bind human anti-porcine antibodies: implications for discordant grafting in man. Transplant Proc. 1992;24:559-562.
12. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IF. Anti-pig IgM antibodies in human serum react predominantly with Galα-3Gal epitopes. Proc Natl Acad Sci U S A. 1993;90:11391-11395.
13. Collins BH, Cotterell AH, McCurry KR, et al. Cardiac xenografts between primate species provide evidence of the α-galactosyl determinant in hyperacute rejection. J Immunol. 1994;154:5500-5510.
14. Galili U, ishida H, Tanabe K, Toma H. Anti-Gal A/B, a novel anti-blood group antibody identified in recipients of ABO incompatible kidney allografts. Transplantation, 2002;74:1574-1580.
15. LaTemple DC, Galili U. Adult and neonatal anti-Gal response in knock-out mice for α1,3galactosyltransferase. Xenotransplantation. 1998;5:191-196.
16. Tanemura M, Yin D, Chong AS, Galili U. Differential immune responses to α-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest. 2000;105:301-310.
17. Yang YG, deGoma E, Ohdan H, et al. Tolerization of anti-Galα1-3Gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med. 1998;187:1335-1342.
18. Ohdan H, Yang YG, Shimizu A, Swenson KG, Sykes M. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Galα1,3Gal-mediated graft rejection. J Clin Invest. 1999;104:281-290.
19. Bracy JL, Sachs DH, Iacomini J. Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science. 1998;281:1845-1847.
20. Bracy JL, Iacomini J. Induction of B-cell tolerance by retroviral gene therapy. Blood. 2000;96:3008-3015.
21. Galili U, LaTemple DC, Radic MZ. A sensitive assay for measuring α-Gal epitope expression on cells by a monoclonal anti-Gal antibody. Transplantation. 1998;65:1129-1132.
22. Ogawa H, Yin D, Shen J, Galili U. Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen. Blood. 2003;101:2318-2320.
23. Springer GF, Horton RE. Blood group isoantibody stimulation in man by feeding blood group-active bacteria. J Clin Invest. 1969;48:1280-1291.
24. Galili U, Anaraki F, Thall A, Hill-Black C, Radic M. One percent of circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood. 1993;82:2485-2493.
25. Tanemura M, Ogawa O, Yin D, Chen Z, DiSesa V, Galili U. Elimination of anti-Gal B cells by α-gal ricin. Transplantation. 2002;73:1859-1868.
26. Narvaiza I, Mazzolini G, Barajas M, et al. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-γ-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy. J Immunol. 2000;164:3112-3122.
27. Cretin N, Bracy J, Hanson K, Iacomini J. The role of T cell help in the production of antibodies specific for Galα1-3Gal. J Immunol. 2002;168:1479-1483.
28. Hartley SB, Crosbie J, Brink R, Kantor AB, Basten A, Goodnow CC. Elimination from peripheral lymohoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature. 1991;353:765-769.
29. Nemazee DA, Burki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature. 1989;337:562-566.
30. Goodnow CC, Brink R, Adams E. Breakdown of self-tolerance in anergic B lymphocytes. Nature. 1991;352:532-536.
31. Radic MZ, Erikson J, Litwin S, Weigert M. B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med. 1993;177:1165-1173.
32. Tiegs SL, Russell DM, Nemazee D. Receptor editing in self-reactive bone marrow B cells. J Exp Med. 1993;177:1009-1020.
33. Speir JA, Abdel-Motal UM, Jondal M, Wilson IA. Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL. Immunity. 1999;10:51-61.
34. Dintzis HM, Dintzis RZ. Profound specific suppression by antigen of persistent IgM, IgG, and IgE antibody production. Proc Natl Acad Sci USA. 1992;89:1113-1117.
35. Bensinger WI, Baker DA, Buckner CD, Clift RA, Thomas ED. Immunoadsorption for removal of A and B blood-group antibodies. N Engl J Med. 1981;304:160-162.
36. Kozlowski T, Shimizu A, Lambrigts D, et al. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. Transplantation. 1999;67:18-30.
37. Deriy L, Chen Z, Gao G, Galili U. Expression of α-gal epitopes on HeLa cells transduced with adenovirus containing α1,3galactosyltransferase cDNA. Glycobiology. 2002;12:135-144.